1) PPARγ ligands
PPARγ受体激动剂
1.
In addition,moderate antineoplastic activities of PPARγ ligands have been observed in patients with liposarcomas and prostate cancers.
近年来体外实验表明PPARγ受体激动剂有抗肿瘤的作用,动物实验也证明了这一点。
2) PPAR γ/agonist
PPARγ/激动剂
3) PPARγ agonists
PPARγ激动剂
1.
Anticancer effects of PPARγ agonists:recent progress;
PPARγ激动剂抗肿瘤作用的研究进展
2.
AIM To build a model of two series of PPARγ agonists thiazolidinedione and aryketo-acid derivatives using 3D-QSAR method, and to reveal the structural features affecting the binding activity to PPARγ, which relates to antihyperglycemic and antihyperlipidemic activity and has a potential application to the treatment of type II diabetes.
目的 建立PPARγ激动剂 噻唑烷二酮和芳酮酸类化合物的三维定量构效关系 ,为设计高活性PPARγ激动剂提供结构信息。
4) Peroxisome proliferator activated receptor-gamma(PPARγ)
过氧化物酶体增殖物激活剂受体-γ(PPARγ)
5) peroxisome proliferate activated receptorγ(PPARγ)
过氧化物酶体增殖剂激活受体γ(PPARγ)
补充资料：受体激动剂
受体激动剂
receptor activating age?nts
能与受体结合，且可使受体激动，从而表现出相应的生理效应或药理作用的药物。例如乙酰胆碱，可与M胆碱受体结合，并使之激动，产生腺体分泌增加，心率减慢、血管扩张、支气管及胃肠道平滑肌收缩和瞳孔缩小等效应。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条